These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33718120)

  • 1. The Prognostic Value of Circulating Soluble Programmed Death Ligand-1 in Cancers: A Meta-Analysis.
    Huang P; Hu W; Zhu Y; Wu Y; Lin H
    Front Oncol; 2020; 10():626932. PubMed ID: 33718120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Soluble Programmed Cell Death Ligand-1 (sPD-L1) in Various Cancers: A Meta-analysis.
    Li X; Zheng Y; Yue F
    Target Oncol; 2021 Jan; 16(1):13-26. PubMed ID: 33222017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis.
    Scirocchi F; Strigari L; Di Filippo A; Napoletano C; Pace A; Rahimi H; Botticelli A; Rughetti A; Nuti M; Zizzari IG
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis.
    Xue JS; Liu H; Meng GX; Ding ZN; Yan LJ; Yao SY; Li HC; Dong ZR; Chen ZQ; Hong JG; Li T
    Cancer Immunol Immunother; 2022 Jul; 71(7):1633-1644. PubMed ID: 34750662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the prognostic value of soluble programmed death ligand-1 (sPD-L1) in cancers.
    Sun J; Hu S; Li X
    Biomarkers; 2023 Sep; 28(6):477-485. PubMed ID: 37017446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis.
    Zhang C; Yang Q
    Front Oncol; 2020; 10():572203. PubMed ID: 33634012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of soluble programmed cell death ligand-1 (sPD-L1) in lymphoma: a systematic review and meta-analysis.
    Ding Y; Sun C; Hu L; Xiong S; Zhai Z
    Ann Hematol; 2023 Sep; 102(9):2425-2434. PubMed ID: 37382610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Significance of Soluble Programmed Death Ligand 1 Expression in Cancers: A Systematic Review and Meta-analysis.
    Ding Y; Sun C; Li J; Hu L; Li M; Liu J; Pu L; Xiong S
    Scand J Immunol; 2017 Nov; 86(5):361-367. PubMed ID: 28930374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive role of soluble programmed death ligand 1 in digestive system cancers.
    Ruan J; Zhao Z; Qian Y; Xu R; Liao G; Kong FS
    Front Oncol; 2023; 13():1170220. PubMed ID: 37519785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma.
    Chang B; Huang T; Wei H; Shen L; Zhu D; He W; Chen Q; Zhang H; Li Y; Huang R; Li W; Wu P
    Cancer Immunol Immunother; 2019 Mar; 68(3):353-363. PubMed ID: 30506460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of programmed cell death-ligand 1 expression on circulating tumor cells in various cancers: A systematic review and meta-analysis.
    Ouyang Y; Liu W; Zhang N; Yang X; Li J; Long S
    Cancer Med; 2021 Oct; 10(20):7021-7039. PubMed ID: 34423578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non-small cell lung cancer treated with anti-PD-1 antibody.
    Murakami S; Shibaki R; Matsumoto Y; Yoshida T; Goto Y; Kanda S; Horinouchi H; Fujiwara Y; Yamamoto N; Ohe Y
    Thorac Cancer; 2020 Dec; 11(12):3585-3595. PubMed ID: 33108686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and prognostic and clinicopathological value of PD-L1 and PD-L2 in renal cell carcinoma patients: a systematic review and meta-analysis involving 3,389 patients.
    Lu Y; Song Y; Xu Y; Ou N; Liang Z; Hu R; Zhang W; Kang J; Wang X; Liu L; Yang Y; Liu X
    Transl Androl Urol; 2020 Apr; 9(2):367-381. PubMed ID: 32420142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble PD-L1 as a predictive biomarker in lung cancer: a systematic review and meta-analysis.
    Cheng Y; Wang C; Wang Y; Dai L
    Future Oncol; 2022 Jan; 18(2):261-273. PubMed ID: 34874185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial.
    Kawakami H; Sunakawa Y; Inoue E; Matoba R; Noda K; Sato T; Suminaka C; Yamaki M; Sakamoto Y; Kawabata R; Ishiguro A; Akamaru Y; Kito Y; Yabusaki H; Matsuyama J; Takahashi M; Makiyama A; Hayashi H; Chamoto K; Honjo T; Nakagawa K; Ichikawa W; Fujii M
    Eur J Cancer; 2023 May; 184():10-20. PubMed ID: 36889037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis.
    Li JH; Ma WJ; Wang GG; Jiang X; Chen X; Wu L; Liu ZS; Zeng XT; Zhou FL; Yuan YF
    Front Immunol; 2018; 9():2077. PubMed ID: 30254644
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic significance of programmed cell death ligand 1 expression in patients with ovarian carcinoma: A systematic review and meta-analysis.
    Huang LJ; Deng XF; Chang F; Wu XL; Wu Y; Diao QZ
    Medicine (Baltimore); 2018 Oct; 97(43):e12858. PubMed ID: 30412078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Role of Soluble Programmed Death Ligand 1 in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Liao G; Zhao Z; Qian Y; Ling X; Chen S; Li X; Kong FS
    Front Oncol; 2021; 11():774131. PubMed ID: 35004295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of circulating soluble programmed death ligand-1 in patients with solid tumors: A meta-analysis.
    Wei W; Xu B; Wang Y; Wu C; Jiang J; Wu C
    Medicine (Baltimore); 2018 Jan; 97(3):e9617. PubMed ID: 29504990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients.
    Wang H; Wang L; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Li ZM; Lu Y
    Oncotarget; 2016 May; 7(22):33035-45. PubMed ID: 27105512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.